ATCC ATCC Logo 0
  • Quick Order
  • Resources
  • Support

Coming Soon from ATCC

Neural progenitor cell derived neurosphere

See what innovative products our team is developing

 

ATCC is committed to providing scientists with the credible, cutting-edge models they need to make breakthroughs in diagnostics development, drug discovery, toxicology profiling, analytical testing, and more. Explore our coming soon products by application for a preview of what our team is developing.

Oncology  Toxicology  Cell biology  Virology  Molecular diagnostics

 

Oncology Products

Immuno-oncology Checkpoint Luciferase Reporter Cells

ATCC is developing a portfolio of luciferase reporter cells with high endogenous expression of immune checkpoint molecules.

  • Wide range of targets such as PD-L1/2, CD-155, B7-H3, PD-1, TIM-3, and others
  • Luciferase will be expressed under the control of GAS, NFAT, or NFκB
  • Exceptional in vitro and ex vivo assay sensitivity and reproducibility

Product Description Availability 
Checkpoint (PD-L1) tumor cell reporter – GAS-Luc2 (ATCC CRL-2868-GAS-Luc2 Available now
Checkpoint (B7-H3) tumor cell reporter – GAS-Luc2  Summer 2023 
Checkpoint (CD-155) tumor cell reporter – GAS-Luc2  Summer 2023 
Checkpoint (PD-1) T cell reporter - GAS-Luc2 Fall 2023 
Checkpoint (TIM-3) T cell reporter – GAS-Luc2 Fall 2023 

 

Sign up for early access and beta-testing opportunities or to be notified when these products are available!

Sign up



Toxicology Products

Primary Hepatocytes & Growth Media – Contact Us

ATCC is developing a complete system of primary hepatocytes and optimized growth media. 

  • High performance (>80% viability)
  • Plate-ability (≥5 days)
  • High cell counts (>5 million cells/vial)
  • Good donor diversity

 

Sign up to request a full list of of our coming soon toxicology products and to be notified when these products are available.

Keep me in the loop



Cell Biology Products

Human Brown and White Pre-adipocytes – Available Spring 2023

Brown adipose cells (BAT) are critical tools for developing therapeutic solutions to metabolic diseases. However, there are few validated cell lines and access to primary tissue is limited. We are overcoming these limitations by developing hTERT-immortalized brown and white pre-adipocytes. 

  • Derived from a single donor
  • Cells express the growth characteristics of a continuous cell but maintain primary cell functionality 
  • Can be differentiated into adipocytes

 

Sign up for early access and beta-testing opportunities or to be notified when these products are available!

Sign up



Virology Products

SARS-CoV-2 Products

Explore the upcoming additions to our portfolio of SARS-CoV-2 reference materials.

Product Description Availability 
Genomic RNA from SARS-CoV-2 strain USA/COR-22-063113/2022 (Omicron variant, lineage BA.5) Spring 2023 
Heat-inactivated SARS-CoV-2 strain USA/COR-22-063113/2022 (Omicron variant, lineage BA.5) Spring 2023
Monoclonal antibody, Anti-SARS-CoV-2 Full Length Spike protein-Clone 5AA7 Spring 2023 
Monoclonal antibody, Anti-SARS-CoV-2 Full Length Spike protein-Clone 5AB3 Spring 2023 
Monoclonal antibody, Anti-SARS-CoV-2 Full Length Spike protein-Clone 5AD5 Spring 2023 
Monoclonal antibody, Anti-SARS-CoV-2 Full Length Spike protein-Clone 5AD9 Spring 2023 
Monoclonal antibody, Anti-SARS-CoV-2 Full Length Spike protein-Clone 5BB4 Spring 2023 

 

Highly Purified Viruses

ATCC is developing highly purified viral spike-ins provided with reference-quality whole-genome sequences.

  • High infectious titer
  • High purity
  • Thorough characterization
Product Description Availability 
Minute virus of mice Winter 2023
Pseudorabies virus Winter 2023
Reovirus 3 Winter 2023
Xenotropic murine leukemia virus-related virus (xMuLV) Winter 2023

 

Sign up to be the first to know when these products are ready!

Keep me in the loop



Molecular Diagnostics Products

Molecular Standards

Check out the ready-to-use, fully authenticated standards we will be adding to our portfolio.

  • Genomic nucleic acids comprise whole-genome preparations isolated from minimally passaged ATCC cultures
  • Synthetic nucleic acids include key target regions from select species
Product Description Availability 
Quantitative Genomic DNA from BK polyomavirus (ATCC VR-837DQ)
Available now
Quantitative Genomic DNA from Canid herpesvirus 1 strain D 004 (ATCC VR-552DQ) Available now
Quantitative Genomic RNA from Parainfluenza virus 4b strain CH 19503  Spring 2023  
Quantitative Genomic RNA from Rubella virus strain M33 (ATCC VR-315DQ) Available now  
Quantitative Genomic DNA from Acinetobacter baumannii strain 2208 Summer 2023
Quantitative Genomic DNA from Clostridioides difficile strain 90556-M6S  Summer 2023  
Quantitative Genomic DNA from Vibrio parahaemolyticus strain EB101 Summer 2023 
Quantitative Genomic DNA from Yersinia enterocolitica strain 33114  Summer 2023 
Quantitative Genomic DNA from Chlamydia trachomatis strain UW-43/Cx  Fall 2023 
Quantitative Genomic DNA from Clostridioides difficile  Fall 2023 
Quantitative Genomic DNA from Neisseria gonorrhoeae strain F-18  Fall 2023  
Quantitative Genomic DNA from Neisseria gonorrhoeae strain NCTC 8375 Fall 2023
Quantitative Genomic DNA from Peptostreptococcus anaerobius strain VPI 4330
Fall 2023 
Quantitative Genomic DNA from Plesiomonas shigelloides strain CDC 3085-55  Fall 2023 
Quantitative Genomic DNA from Serratia marcescens subsp. marcescens strain BS 303  Fall 2023 
Quantitative Genomic DNA from Streptococcus salivarius subsp. salivarius strain C699 Fall 2023 
Quantitative Genomic DNA from Trichomonas vaginalis strain CDC 085
Fall 2023 
Quantitative Genomic RNA from Measles virus strain Edmonston  Fall 2023 
Quantitative Genomic DNA from Bacillus atrophaeus strain NRS 1221A  Winter 2023 
Quantitative Genomic DNA from Human Adenovirus D strain Trim  Winter 2023 
Quantitative Genomic DNA from Lactobacillus acidophilus strain SCAV  Winter 2023 
Quantitative Genomic DNA from Salmonella enterica subsp. enterica strain CDC K-1891  Winter 2023 
Quantitative Synthetic RNA for Influenza A virus (H1N1) strain A/Brisbane/59/07
Winter 2023 
Quantitative Synthetic RNA for Influenza A virus (H1N1)pdm2009 strain A/Brisbane/02/2018
Winter 2023 
Quantitative Synthetic RNA for Influenza A virus (H3N2) strain A/Hiroshima/52/2005  Winter 2023 
Quantitative Synthetic RNA for Influenza B virus strain B/Brisbane/60/2008 Winter 2023 
Quantitative Synthetic RNA for Influenza B virus strain B/Malaysia/2506/2004
Winter 2023 

Microbial panels

We are developing microbial panels comprising quantitative genomic molecular standards. The panels will be offered at bulk discount pricing, allowing you to take advantage of cost savings as compared to individual items.

Product Description Availability 
Enteric exclusivity panel  Fall 2023 
Enteric pathogen panel Fall 2023
Sexually transmitted infection (STI) exclusivity panel
Fall 2023
Sexually transmitted infection (STI) pathogen panel Fall 2023

 

Want more information about these products or to be notified when they are ready? Join our list!

Keep me in the loop

Contact us



Please input 10 numbers.




Your form was successfully submitted
CAR-T cells, CAR-Target, CD19, CD20, HER2

Check out our newest releases

Browse new products